• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

滤泡性淋巴瘤:临床特征与治疗

Follicular lymphoma: clinical features and treatment.

作者信息

Tan Daryl, Horning Sandra J

机构信息

Department of Hematology, Singapore General Hospital, Outram Road, Singapore 169608.

出版信息

Hematol Oncol Clin North Am. 2008 Oct;22(5):863-82, viii. doi: 10.1016/j.hoc.2008.07.013.

DOI:10.1016/j.hoc.2008.07.013
PMID:18954741
Abstract

Follicular lymphoma (FL) is the second most common subtype of non-Hodgkin's lymphoma (NHL) in the Western world, constituting up to 22% of the total cases of NHL. This article describes the clinical characteristics of FL, its prognostic indicators, and its clinical course, including transformation to an aggressive lymphoma. Primary management and therapies for recurrent FL are detailed.

摘要

滤泡性淋巴瘤(FL)是西方世界非霍奇金淋巴瘤(NHL)的第二大常见亚型,占NHL总病例的22%。本文描述了FL的临床特征、预后指标及其临床病程,包括向侵袭性淋巴瘤的转化。还详细介绍了复发性FL的初始管理和治疗方法。

相似文献

1
Follicular lymphoma: clinical features and treatment.滤泡性淋巴瘤:临床特征与治疗
Hematol Oncol Clin North Am. 2008 Oct;22(5):863-82, viii. doi: 10.1016/j.hoc.2008.07.013.
2
Follicular non-Hodgkin's lymphoma.滤泡性非霍奇金淋巴瘤。
Clin Radiol. 2010 May;65(5):408-20. doi: 10.1016/j.crad.2010.01.010. Epub 2010 Mar 15.
3
Population-based analysis of incidence and outcome of transformed non-Hodgkin's lymphoma.基于人群的转化型非霍奇金淋巴瘤发病率及转归分析
J Clin Oncol. 2008 Nov 10;26(32):5165-9. doi: 10.1200/JCO.2008.16.0283. Epub 2008 Oct 6.
4
Prognostic factors in follicular lymphoma.滤泡性淋巴瘤的预后因素。
J Clin Oncol. 2010 Jun 10;28(17):2902-13. doi: 10.1200/JCO.2009.26.1693. Epub 2010 Apr 12.
5
Prognosis of follicular lymphomas.滤泡性淋巴瘤的预后
Hematol Oncol. 2006 Jun;24(2):64-72. doi: 10.1002/hon.772.
6
Primary gastrointestinal follicular lymphoma: a clinicopathologic study of 13 cases from Taiwan.原发性胃肠道滤泡性淋巴瘤:来自台湾的13例临床病理研究
J Clin Gastroenterol. 2008 Oct;42(9):997-1002. doi: 10.1097/MCG.0b013e3180f62b12.
7
Prognosis of primary thyroid lymphoma: demographic, clinical, and pathologic predictors of survival in 1,408 cases.原发性甲状腺淋巴瘤的预后:1408例患者生存情况的人口统计学、临床及病理预测因素
Surgery. 2009 Dec;146(6):1105-15. doi: 10.1016/j.surg.2009.09.020.
8
What is remission in follicular lymphoma and what is its relevance?滤泡性淋巴瘤中的缓解是什么,其意义何在?
Best Pract Res Clin Haematol. 2005 Mar;18(1):27-56. doi: 10.1016/j.beha.2004.08.019.
9
Monoclonal antibody therapies for follicular non-Hodgkin's lymphomas: moving toward a cure.用于滤泡性非霍奇金淋巴瘤的单克隆抗体疗法:迈向治愈之路。
ONS Connect. 2007;22(8 Suppl):39-40.
10
The clinical course of follicular lymphoma.滤泡性淋巴瘤的临床病程。
Best Pract Res Clin Haematol. 2005 Mar;18(1):1-10. doi: 10.1016/j.beha.2004.06.002.

引用本文的文献

1
Management of Aggressive Non-Hodgkin Lymphomas in the Pediatric, Adolescent, and Young Adult Population: An Adult vs. Pediatric Perspective.儿童、青少年及青年人群侵袭性非霍奇金淋巴瘤的管理:成人视角与儿童视角对比
Cancers (Basel). 2022 Jun 13;14(12):2912. doi: 10.3390/cancers14122912.
2
Assessing the Effectiveness of Treatment Sequences for Older Patients With High-risk Follicular Lymphoma With a Multistate Model.使用多状态模型评估高危滤泡性淋巴瘤老年患者治疗序列的有效性。
Clin Lymphoma Myeloma Leuk. 2019 May;19(5):300-309.e5. doi: 10.1016/j.clml.2018.12.019. Epub 2019 Jan 3.
3
BCL6 Antagonizes NOTCH2 to Maintain Survival of Human Follicular Lymphoma Cells.
BCL6拮抗NOTCH2以维持人滤泡性淋巴瘤细胞的存活。
Cancer Discov. 2017 May;7(5):506-521. doi: 10.1158/2159-8290.CD-16-1189. Epub 2017 Feb 23.
4
Primary Follicular Lymphoma of the Gastrointestinal Tract: Case Report and Review.胃肠道原发性滤泡性淋巴瘤:病例报告与文献复习
J Gastrointest Cancer. 2016 Sep;47(3):255-63. doi: 10.1007/s12029-016-9847-z.
5
90-yttrium-ibritumomab tiuxetan consolidation of fludarabine, mitoxantrone, rituximab in intermediate/high-risk follicular lymphoma: updated long-term results after a median follow-up of 7 years.钇-90替伊莫单抗巩固治疗氟达拉滨、米托蒽醌、利妥昔单抗用于中/高危滤泡性淋巴瘤:中位随访7年后的长期结果更新
Cancer Med. 2016 Jun;5(6):1093-7. doi: 10.1002/cam4.684. Epub 2016 Mar 14.
6
Treatment outcomes and clinical relevance of the Follicular Lymphoma International Prognostic Index in Korean follicular lymphoma patients treated with chemotherapy.韩国滤泡性淋巴瘤患者化疗治疗中滤泡性淋巴瘤国际预后指数的治疗结果及临床相关性
Korean J Intern Med. 2016 May;31(3):560-9. doi: 10.3904/kjim.2014.222. Epub 2016 Feb 22.
7
Comparing the cost-effectiveness of rituximab maintenance and radioimmunotherapy consolidation versus observation following first-line therapy in patients with follicular lymphoma.比较利妥昔单抗维持治疗和放射免疫治疗巩固治疗与滤泡性淋巴瘤患者一线治疗后观察的成本效益。
Value Health. 2015 Mar;18(2):189-97. doi: 10.1016/j.jval.2014.12.017.
8
Current role of FDG PET/CT in lymphoma.氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(FDG PET/CT)在淋巴瘤中的当前作用
Eur J Nucl Med Mol Imaging. 2014 May;41(5):1004-27. doi: 10.1007/s00259-013-2686-2. Epub 2014 Feb 12.
9
State-of-the-Art Research on "Lymphomas: Role of Molecular Imaging for Staging, Prognostic Evaluation, and Treatment Response".“淋巴瘤:分子成像在分期、预后评估及治疗反应中的作用”的前沿研究
Front Oncol. 2013 Sep 4;3:212. doi: 10.3389/fonc.2013.00212.
10
Initial management strategies for follicular lymphoma.滤泡性淋巴瘤的初始管理策略
Int J Hematol Oncol. 2012 Oct;1(1):35-45. doi: 10.2217/ijh.12.7.